We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer biomarkers. The paper list is as follows:

1. “Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer—Current Use and Future Opportunities”
by Lara Paracchini, Maurizio D’Incalci and Sergio Marchini
Cancers 2021, 13(10), 2386; https://doi.org/10.3390/cancers13102386
Available online: https://www.mdpi.com/2072-6694/13/10/2386

2. “Direct Regulation of DNA Repair by E2F and RB in Mammals and Plants: Core Function or Convergent Evolution?”
by Swarnalatha Manickavinayaham, Briana K. Dennehey and David G. Johnson
Cancers 2021, 13(5), 934; https://doi.org/10.3390/cancers13050934
Available online: https://www.mdpi.com/2072-6694/13/5/934

3. “From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine”
by Sean M. Hacking, Evgeny Yakirevich and Yihong Wang
Cancers 2022, 14(14), 3469; https://doi.org/10.3390/cancers14143469
Available online: https://www.mdpi.com/2072-6694/14/14/3469

4. “Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups”
by Emilia Bevacqua, Jasmin Farshchi, Maria Victoria Niklison-Chirou and Paola Tucci
Cancers 2021, 13(24), 6323; https://doi.org/10.3390/cancers13246323
Available online: https://www.mdpi.com/2072-6694/13/24/6323

5. “Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model”
by Gloria M. Calaf, Leodan A. Crispin, Debasish Roy, Francisco Aguayo, Juan P. Muñoz and Tammy C. Bleak
Cancers 2021, 13(18), 4571; https://doi.org/10.3390/cancers13184571
Available online: https://www.mdpi.com/2072-6694/13/18/4571

6. “Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer”
by Arkadiusz Gajek, Patrycja Gralewska, Agnieszka Marczak and Aneta Rogalska
Cancers 2021, 13(11), 2690; https://doi.org/10.3390/cancers13112690
Available online: https://www.mdpi.com/2072-6694/13/11/2690

7. “Rationale for Early Detection of EWSR1 Translocation-Associated Sarcoma Biomarkers in Liquid Biopsy”
by Felix I. L. Clanchy
Cancers 2021, 13(4), 824; https://doi.org/10.3390/cancers13040824
Available online: https://www.mdpi.com/2072-6694/13/4/824

8. “Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence”
by Ikuko Kato, Jilei Zhang and Jun Sun
Cancers 2022, 14(2), 425; https://doi.org/10.3390/cancers14020425
Available online: https://www.mdpi.com/2072-6694/14/2/425

9. “Challenges for Better Diagnosis and Management of Pancreatic and Biliary Tract Cancers Focusing on Blood Biomarkers: A Systematic Review”
by Hiroto Tominaga, Juntaro Matsuzaki, Chihiro Oikawa, Kensho Toyoshima, Haruki Manabe, Eriko Ozawa, Atsushi Shimamura, Riko Yokoyama, Yusuke Serizawa, Takahiro Ochiya et al.
Cancers 2021, 13(16), 4220; https://doi.org/10.3390/cancers13164220
Available online: https://www.mdpi.com/2072-6694/13/16/4220

10. “Proteomics as a Complementary Technique to Characterize Bladder Cancer”
by Rubén López-Cortés, Sergio Vázquez-Estévez, Javier Álvarez Fernández and Cristina Núñez
Cancers 2021, 13(21), 5537; https://doi.org/10.3390/cancers13215537
Available online: https://www.mdpi.com/2072-6694/13/21/5537

11. “Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance”
by Shugo Sakihama and Kennosuke Karube
Cancers 2022, 14(10), 2394; https://doi.org/10.3390/cancers14102394
Available online: https://www.mdpi.com/2072-6694/14/10/2394

12. “miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine”
by Mara Fernandes, Herlander Marques, Ana Luísa Teixeira and Rui Medeiros
Cancers 2021, 13(24), 6324; https://doi.org/10.3390/cancers13246324
Available online: https://www.mdpi.com/2072-6694/13/24/6324

13. “The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization”
by Hishan Tharmaseelan, Alexander Hertel, Shereen Rennebaum, Dominik Nörenberg, Verena Haselmann, Stefan O. Schoenberg and Matthias F. Froelich
Cancers 2022, 14(14), 3349; https://doi.org/10.3390/cancers14143349
Available online: https://www.mdpi.com/2072-6694/14/14/3349

14. “A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis”
by Peter Shaw, Raghul Senthilnathan, Sunil Krishnan, Deepa Suresh, Sameep Shetty, Gothandam Kodiveri Muthukaliannan, Ravishankar Ram Mani, Palanisamy Sivanandy, Harish Chinna Konda Chandramoorthy, Madan Mohan Gupta et al.
Cancers 2021, 13(17), 4369; https://doi.org/10.3390/cancers13174369
Available online: https://www.mdpi.com/2072-6694/13/17/4369

15. “Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer”
by Signe B. Clemmensen, Jennifer R. Harris, Jonas Mengel-From, Wagner H. Bonat, Henrik Frederiksen, Jaakko Kaprio and Jacob v. B. Hjelmborg
Cancers 2021, 13(12), 3023; https://doi.org/10.3390/cancers13123023
Available online: https://www.mdpi.com/2072-6694/13/12/3023

You can check more information about the Section “Cancer Biomarkers” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Biomarkers.